Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride is more effective and satisfactory than montelukast for treating moderate acne in women.

Certolizumab effectively treats psoriasis and psoriatic arthritis with fewer side effects than adalimumab.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

SIG-1451 could be a promising new treatment for atopic dermatitis.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

The meeting presented findings on effective treatments for various pet skin conditions and insights into the immune responses of dogs with atopic dermatitis.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Astaxanthin is a safe antioxidant that may improve heart, skin, eye health, and physical performance, and help manage chronic diseases.

Oclacitinib effectively treated a diabetic cat's severe skin issues without raising glucose levels, and surgery fixed eyelid fusion.

The microneedle patches effectively treat allergic conjunctivitis with controlled, sustained release of medication.

Fipronil effectively treats Lynxacarus radovskyi in outdoor cats.

Recombinant Human Annexin A5 may help treat localized scleroderma by reducing skin thickening and inflammation.

Anifrolumab improves quality of life and reduces steroid use in SLE patients.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Dupilumab and oral JAK inhibitors are effective for treating alopecia areata with atopic diseases.

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

A new cream, DHMEQ, reduces allergic skin inflammation effectively.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

Daclizumab may cause psoriasis-like skin problems in multiple sclerosis patients.

Cepharanthine dry powder inhalers may effectively treat acute lung injury by reducing inflammation.

The dog's skin condition improved quickly with treatment and did not return.

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.